Citius Oncology Q1 2026 Earnings Wide EPS Miss Highlights PreRevenue Challenges MAXN Q4 2024 Earnings Massive Earnings Beat Signals Operational Improvement Amidst Solar Headwinds TTGT Q1 2026 Earnings Significant EPS Miss as Losses Widen Stock Gains Unexpectedly NTR Q1 2026 Earnings EPS Miss Weighs on Shares as Fertilizer Margins Tighten CCID Q1 2026 Earnings Preferred Shares Rise Despite Significant EPS Miss KMDA Kamada reports Q4 2025 EPS below analyst estimates as shares post tiny gains in daily trading Kayne Anderson BDC Inc KBDC Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response